Concepedia

Yi Chu Liang

YC

5

Publications

109

Citations

5

H-Index

2022

Active since

Affiliations

Institute of Infection and Immunity(Current)

University of Ottawa

First Affiliated Hospital of Anhui Medical University

Anhui Medical University

Houston Methodist

Yi Chu Liang is an author at Institute of Infection and Immunity specializing in tuberculosis, drug resistance, and tuberculosis prevention.

ORCID

Top concepts

Publications per year

2022–2022

5

Publications

5

TREM2 Promotes Immune Evasion by Mycobacterium tuberculosis in Human Macrophages

Ankita Dabla, Yi Chu Liang, Nusrah Rajabalee et al. · mBio · 2022 · 43 citations · Full text

A selective PPM1A inhibitor activates autophagy to restrict the survival of Mycobacterium tuberculosis

Stefania Berton, Lu Chen, Yi Chu Liang et al. · Cell chemical biology · 2022 · 24 citations

, , +12

LncRNA LINC00461 exacerbates myocardial ischemia–reperfusion injury via microRNA-185-3p/Myd88

Feng Gao, Xiaochen Wang, Tingting Fan et al. · Molecular Medicine · 2022 · 17 citations · Full text

LncRNA HOXA11-AS Promotes Vascular Endothelial Cell Injury in Atherosclerosis by Regulating the miR-515-5p/ROCK1 Axis

Feng Gao, Xiaochen Wang, Zhidan Luo et al. · ESC Heart Failure · 2022 · 14 citations · Full text

An in vivo biosafety-level-2-compatible model of Mycobacterium tuberculosis infection for drug susceptibility testing

Yi Chu Liang, Stefania Berton, Courtney Reeks et al. · STAR Protocols · 2022 · 11 citations · Full text

Rows per page

1–5 of 5